Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS
Shalom Haggiag, Luca Prosperini, Massimo Filippi, Maria A. Rocca, Pietro Iaffaldano, Francesco Patti, Matilde Inglese, Giovanna Borriello, Rocco Totaro, Giacomo Lus, Roberta Fantozzi, Vincenzo Brescia Morra, Silvia Romano, Jessica Frau, Girolama Alessandra Marfia, Giorgia Teresa Maniscalco, Maria Pia Amato, Alessia Di Sapio, Giovanna De Luca, Sebastiano Giuseppe Crisafulli, Erica Curti, Matteo Foschi, Paola Cavalla, Giuseppe Salemi, Antonella Conte, Paola Valentino, Diana Ferraro, Alessandra Lugaresi, Sabrina Realmuto, Paola Perini, Elisabetta Ferraro, Sara Montepietra, Carlo Avolio, Marika Vianello, Paola Gazzola, Fabiana Marinelli, Livia Pasquali, Sebastiano Bucello, Domizia Vecchio, Alessandra Protti, Francesca Sangalli, Marco Rovaris, Luigi Grimaldi, Milena De Riz, Paolo Barone, Valentina Scarano, Bonaventura Ardito, Leonardo Sinisi, Paolo Immovilli, Ilaria Pesci, Elena Colombo, Marco Capobianco, Cristina Fioretti, Maria Gabriella Coniglio, Antonello Giordano, Tiziana Tassinari, Daniela Cargnelutti, Francesca Matta, Mario Falcini, Maurizia Gatto, Nerina Mascoli, Roberto Balgera, Sessa Edoardo, Rosa Iodice, Claudio Solaro, Katrin Plewnia, Mario Santangelo, Valeria Barcella, Maria Teresa Ferrò, Francesco Sica, Raffaella Cerqua, Giuseppe Santuccio, Francesco Corea, Alessandro Leone, Davide Nasuelli, Augusto Maria Rini, Giampaolo Brichetto, Salvatore Cottone, Monica Ulivelli, Matteo Pizzorno, Patrizia Rossi, Eva Milano, Luigi Zuliani, Serena Ruggieri, Claudio Gasperini, María Trojano, Carla Tortorella (2025). Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MS. , 8(11), DOI: https://doi.org/10.1001/jamanetworkopen.2025.41025.
Article59 days agoImplementing proximity care for people with multiple sclerosis in Italy: the bottom-up approach of the StayHome project
Massimo Filippi, Pia Grassivaro Gallo, C. Gasperini, Gerolama Alessandra Marfia, Carlo Avolio, Roberto Bergamaschi, Marco Capobianco, M. Dotta, Luigi Grimaldi, Giacomo Lus, F. Patti, Eugenio Pucci, R. Quatrale, Paolo Solla, Paolo Bandiera, Carmen Angioletti, Marina Gallottini, Simone Parretti, Luiz Ricardo Pinto, Francesco S. Pavone, Sveva Sanzone (2025). Implementing proximity care for people with multiple sclerosis in Italy: the bottom-up approach of the StayHome project. , 272(1), DOI: https://doi.org/10.1007/s00415-024-12749-8.
Article59 days agoCovid-19 Outbreak in Italy: An Opportunity to Evaluate Extended Interval Dosing of Ocrelizumab in MS Patients (P2-6.010)
Alvino Bisecco, Federica Matrone, Marco Capobianco, Giovanna De Luca, Massimo Filippi, Franco Granella, Giacomo Lus, Girolama Alessandra Marfia, Massimiliano Mirabella, Francesco Patti, María Trojano, Agnese Mascolo, Massimiliano Copetti, Gioacchino Tedeschi, Antonio Gallo (2024). Covid-19 Outbreak in Italy: An Opportunity to Evaluate Extended Interval Dosing of Ocrelizumab in MS Patients (P2-6.010). , 102(7_supplement_1), DOI: https://doi.org/10.1212/wnl.0000000000206347.
Article59 days agoEfficacy and safety of ublituximab for relapsing multiple sclerosis patients: current evidence and expert opinion
Paolo Preziosa, Vincenzo Brescia Morra, Marco Capobianco, Claudio Gasperini, Luigi Maria Edoardo Grimaldi, Girolama Alessandra Marfia, Damiano Paolicelli, Paola Perini, Valentina Torri Clerici, Massimo Filippi (2025). Efficacy and safety of ublituximab for relapsing multiple sclerosis patients: current evidence and expert opinion. , 272(10), DOI: https://doi.org/10.1007/s00415-025-13442-0.
Article59 days agoEfficacy and safety of ublituximab for relapsing multiple sclerosis patients: current evidence and expert opinion
Paolo Preziosa, Vincenzo Brescia Morra, Marco Capobianco, Claudio Gasperini, Luigi Maria Edoardo Grimaldi, Girolama Alessandra Marfia, Damiano Paolicelli, Paola Perini, Valentina Torri Clerici, Massimo Filippi (2025). Efficacy and safety of ublituximab for relapsing multiple sclerosis patients: current evidence and expert opinion. , 272(10), DOI: https://doi.org/10.1007/s00415-025-13442-0.
Article59 days ago